Energy-based devices for the treatment of Acne Scars: 2022 International consensus recommendations.
acne scars
energy based devices
lasers
Journal
Lasers in surgery and medicine
ISSN: 1096-9101
Titre abrégé: Lasers Surg Med
Pays: United States
ID NLM: 8007168
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
24
09
2021
accepted:
03
10
2021
pubmed:
1
11
2021
medline:
28
1
2022
entrez:
31
10
2021
Statut:
ppublish
Résumé
Acne scars are one of the most distressing and long-term consequences of acne vulgaris, with damaging effect on a person's physical, mental, and social well-being. Numerous treatment options are available including surgical and nonsurgical techniques, depending on the clinical presentation. Although considerable advances in the development of new treatment technologies and applications have been made in the last decade, international treatment guidelines and reimbursement schemes have not yet caught up with current knowledge and practice in many centers. The authors intend to highlight the potential utility of energy-based devices (EBDs) for acne scarring, offer recommendations for safe and efficacious treatment, and provide consensus-based EBD treatment options based on varying presentations demonstrated in a series of real-life clinical photographs. An international panel of 24 dermatologists and plastic surgeons from 12 different countries and a variety of practice backgrounds was self-assembled to develop updated consensus recommendations for the treatment of acne scars. A two-step modified Delphi method took place between March 2020 and February 2021 consisting of two rounds of emailed questionnaires. The panel members approved the final manuscript via email correspondence. The manuscript includes a comprehensive discussion and panel recommendations regarding the following topics: 1. the role of EBD in mitigating and treating acne scars in a patient with active acne, 2. the use of various EBDs for the treatment of different acne scar types with special focus on commonly used laser platform such as vascular lasers, ablative fractional lasers (AFLs) and non-AFLs (NAFLs), 3. treatment combinations, and 4. acne scar treatments in skin of color. The last part comprised of 10 photos of real-life clinical cases with the panel recommendation treatment plan to achieve best aesthetic outcome. Panel members were unanimous in their view that EBDs have a role in the management of acne scars, with AFLs, NAFLs, vascular lasers, and RF devices preferentially selected by most of the panel experts. EBDs are considered a first-line treatment for a variety of acne scar types and patients without access to these treatments may not be receiving the best available care for optimal cosmetic results. Future high-quality research and updated international treatment guidelines and reimbursement schemes should reflect this status.
Sections du résumé
BACKGROUND AND OBJECTIVES
Acne scars are one of the most distressing and long-term consequences of acne vulgaris, with damaging effect on a person's physical, mental, and social well-being. Numerous treatment options are available including surgical and nonsurgical techniques, depending on the clinical presentation. Although considerable advances in the development of new treatment technologies and applications have been made in the last decade, international treatment guidelines and reimbursement schemes have not yet caught up with current knowledge and practice in many centers. The authors intend to highlight the potential utility of energy-based devices (EBDs) for acne scarring, offer recommendations for safe and efficacious treatment, and provide consensus-based EBD treatment options based on varying presentations demonstrated in a series of real-life clinical photographs.
STUDY DESIGN/MATERIALS AND METHODS
An international panel of 24 dermatologists and plastic surgeons from 12 different countries and a variety of practice backgrounds was self-assembled to develop updated consensus recommendations for the treatment of acne scars. A two-step modified Delphi method took place between March 2020 and February 2021 consisting of two rounds of emailed questionnaires. The panel members approved the final manuscript via email correspondence.
RESULTS
The manuscript includes a comprehensive discussion and panel recommendations regarding the following topics: 1. the role of EBD in mitigating and treating acne scars in a patient with active acne, 2. the use of various EBDs for the treatment of different acne scar types with special focus on commonly used laser platform such as vascular lasers, ablative fractional lasers (AFLs) and non-AFLs (NAFLs), 3. treatment combinations, and 4. acne scar treatments in skin of color. The last part comprised of 10 photos of real-life clinical cases with the panel recommendation treatment plan to achieve best aesthetic outcome.
CONCLUSION
Panel members were unanimous in their view that EBDs have a role in the management of acne scars, with AFLs, NAFLs, vascular lasers, and RF devices preferentially selected by most of the panel experts. EBDs are considered a first-line treatment for a variety of acne scar types and patients without access to these treatments may not be receiving the best available care for optimal cosmetic results. Future high-quality research and updated international treatment guidelines and reimbursement schemes should reflect this status.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
10-26Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Goodman GJ. Post acne scarring: a review of its pathophysiology and treatment. Dermatol Surg. 2000;26(9):857-71.
Fabbrocini G, Annunziata MC, D'arco V, De Vita V, Lodi G, Mauriello MC, et al. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010;2010:893080.
Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;19:303-8.
Holland DB, Jeremy AHT, Roberts SG, Seukeran DC, Layton AM, Cunliffe WJ. Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. Br J Dermatol. 2004;150:72-81.
Fife D. Practical evaluation and management of atrophic acne scars: tips for the general dermatologist. J Clin Aesthet Dermatol. 2011;4(8):50-7.
Tasoula E. The impact of acne vulgaris on quality of life and psychic health in young adolescents in Greece. Results of a population survey. An Bras Dermatol. 2012;87(6):862-9.
Lee WJ, Jung HJ, Lim HJ, Jang YH, Lee SJ, Kim DW. Serial sections of atrophic acne scars help in the interpretation of microscopic findings and the selection of good therapeutic modalities. J Eur Acad Dermatol Venereol. 2013;27:643-6.
Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;19:303-8.
Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol. 2001;45:109-17.
Goodman GJ, Baron JA. Postacne scarring: a qualitative global scarring grading system. Dermatol Surg. 2006;32(no. 12):1458-66.
Levy LL, Zeichner JA. Management of acne scarring, part II: a comparative review of non-laser-based, minimally invasive approaches. Am J Clin Dermatol. 2012;13(5):331-40.
Monica B, Carolyn J. A review and update of treatment options using the acne scar classification system. Dermatol Surg. 2019;45(3):411-22.
Finlay AY, Torres V, Kang S, Bettoli V, Dreno B, Goh CL, et al. Classification of acne scars is difficult even for acne experts. J Eur Acad Dermatol Venereol. 2013;27(3):391-3.
Shashank Bhargava PR, Cunha J, Lee GK. Acne scarring management: systematic review and evaluation of the evidence. Am J Clin Dermatol. 2018;19(4):459-47.
Basta-Juzbasic A. Current therapeutic approach to acne scars. Acta Dermatovenerol Croat. 2010;18(3):171-5.
Abdel Hay R, Shalaby K, Zaher H, Hafez V, Chi CC, Dimitri S, et al. Interventions for acne scars. Cochrane Database Syst Rev. 2016;4:CD011946.
Seago M, Shumaker PR, Spring LK, Alam M, Al-Niaimi F, Rox Anderson R, et al. Laser treatment of traumatic scars and contractures: 2020 international consensus recommendations. Lasers Surg Med. 2020;52:96-116.
Dalkey N. The Delphi method: an experimental study of group opinion. Futures. 1969;1:408-26.
Tan J, Kang S, James L. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the USA. J Drugs Dermatol. 2017;16(2):97-102.
Mohamed EE, Tawfik K, Mohamed E. Intense pulsed light versus 1,064 long-pulsed neodymium: yttrium-aluminum-garnet laser in the treatment of facial acne vulgaris. J Clin Diagn Res. 2016;10(7):WC01-03.
Wat H, Wu DC, Rao J, Goldman MP. Application of intense pulsed light in the treatment of dermatologic disease: a systematic review. Dermatol Surg. 2014;40(4):359-77.
Wiznia LE, Stevenson ML, Nagler AR. Laser treatments of active acne. Lasers Med Sci. 2017;32(7):1647-58.
Koceva I, Rümmelein B, Gerber PA, Edge D, Nielsen MCE. Fluorescent light energy: a new therapeutic approach to effectively treating acne conglobata and hidradenitis suppurativa. Clin Case Rep. 2019;7(9):1769-72. doi:10.1002/ccr3.2334
Edge D, Mellergaard M, Dam-Hansen C, Corell DD, Jaworska J, Scapagnini G, et al. Fluorescent light energy: the future for treating inflammatory skin conditions? J Clin Aesthet Dermatol. 2019;12(5):E61-8.
Moneib H, Tawfik AA, Youssef SS, Fawzy MM. Randomized split-face controlled study to evaluate 1550-nm fractionated erbium glass laser for treatment of acne vulgaris-an image analysis evaluation. Dermatol Surg. 2014;40(11):1191-200.
Seaton ED, Mouser PE, Charakida A, Alam S, Seldon PE, Chu AC. Investigation of the mechanism of action of nonablative pulsed-dye laser therapy in photorejuvenation and inflammatory acne vulgaris. Br J Dermatol. 2006;155(4):748-55.
Jasim ZF, Al-Qarqaz F, Handley JM. To the editor: effect of single pulsed dye laser treatment on acne vulgaris. Dermatol Surg. 2005;31(11 Pt 1):1483.
Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the global alliance to improve outcomes in acne group. J Am Acad Dermatol. 2009;60(5 suppl):S1-50.
Kim ST, Lee KH, Sim HJ, Suh KS, Jang MS. Treatment of acne vulgaris with fractional radiofrequency microneedling. J Dermatol. 2014;41(7):586-91.
Zeng R, Liu Y, Zhao W, Yang Y, Wu Q, Li M, et al. A split-face comparison of a fractional microneedle radiofrequency device and fractional radiofrequency therapy for moderate-to-severe acne vulgaris. J Cosmet Dermatol. 2020;19(10):2566-71.
Kim J, Lee YI, Kim J, Jung JY, Lee WJ, Lee JH. Safety of combined fractional microneedle radiofrequency and CO2 as an early intervention for inflammatory acne and scarring treated with concomitant isotretinoin. Dermatol Surg. 2020;46(10):e71-7.
Strauss JS, Krowchuk DP, Leyden JJ. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56:651-63.
Amichai B, Shemer A, Grunwald MH. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol. 2006;54:644-6.
Goldstein JA, Socha-Szott A, Thomsen RJ, Pochi PE, Shalita AR, Strauss JS. Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion. J Am Acad Dermatol. 1982;6:760-5.
Jones DH, King K, Miller AJ, Cunliffe WJ. A dose-response study of I3-cis-retinoic acid in acne vulgaris. Br J Dermatol. 1983;108:333-43.
Layton AM, Knaggs H, Taylor J, Cunliffe WJ. Isotretinoin for acne vulgarise10 years later: a safe and successful treatment. Br J Dermatol. 1993;129:292-6.
Spring LK, Krakowski AC, Alam M, Bhatia A, Brauer J, Cohen J, et al. Isotretinoin and timing of procedural interventions. A systematic review with consensus recommendations. JAMA Dermatol. 2017;153:802-9.
Waldman A, Bolotin D, Arndt KA, Dover JS, Geronemus RG, Chapas A, et al. ASDS guidelines task force: Consensus recommendations regarding the safety of lasers, dermabrasion, chemical peels, energy devices, and skin surgery during and after isotretinoin use. Dermatol Surg. 2017;43:1249-62.
Spring LK, Krakowski AC, Alam M, Bhatia A, Brauer J, Cohen JL, et al. Isotretinoin and timing of procedural interventions: a systematic review with consensus recommendations. JAMA Dermatol. 2017;153(8):802-9.
Prather HB, Alam M, Poon E, Arndt KA, Dover JS. Laser safety in isotretinoin use: a survey of expert opinion and practice. Dermatol Surg. 2017;43:357-63.
Gold MH, Manturova NE, Kruglova LS, Ikonnikova EV. Treatment of moderate to severe acne and scars with a 650-microsecond 1064-nm38 laser and isotretinoin. J Drugs Dermatol. 2020;19:646-51.
Gao L, Wang L, Li K, Tan Q, Lu M, Li Y, et al. Treatment of acne vulgaris using 1,565 nm non-ablative fractional laser in combination with isotretinoin and pricking blood therapy. J Dermatol Treat. 2020;19:1-7.
Xia J, Hu G, Hu D, Geng S, Zeng W. Concomitant use of the 1,550-nm nonablative fractional laser with low-dose isotretinoin for the treatment of acne vulgaris in Asian patients: a randomized split-face controlled study. Dermatol Surg. 2018;44:1201-8.
Ibrahim SM, Farang A, Hegazy R, Mongy M, Shalaby S, Kamel MM. Combined low-dose isotretinoin and pulsed dye laser versus standard-dose isotretinoin in the treatment of inflammatory acne. Lasers Surg Med. 2020;53(5):603-9.
Kroepfl L, Emer JJ. Combination therapy for acne scarring: personal experience and clinical suggestions. J Drugs Dermatol. 2016;15(11):1413-9.
Cohen BE, Brauer JA, Geronemus RG. Acne scarring: a review of available therapeutic lasers. Lasers Surg Med. 2016;48(2):95-115.
Rivera AE. Acne scarring: a review and current treatment modalities. J Am Acad Dermatol. 2008;59(4):659-76.
Kirsanova L, Araviiskaia E, Rybakova M, Sokolovsky E, Bogantenkov A, Al-Niaimi F. Histological characterization of age-related skin changes following the use of picosecond laser: low vs high energy. Dermatol Ther. 2020;33(4):e13635.
Sadick NS, Cardona A. Laser treatment for facial acne scars: a review. J Cosmet Laser Ther. 2018;20(7-8):424-35.
Goerge T, Peukert N, Bayer H, Rutter A. Ablative fractional photothermolysis-a novel in skin resurfacing. Med Laser Appl. 2008;23:93-8.
Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol. 2008;58:719-37.
Juhasz MLW, Cohen JL. Microneedling for the treatment of scars: an update for clinicians. Clin Cosmet Investig Dermatol. 2020;13:997-1003.
Kang WH, Kim YJ, Pyo WS, Park SJ, Kim JH. Atrophic acne scar treatment using triple combination therapy: dot peeling, subcision and fractional laser. J Cosmet Laser Ther. 2009;11:212-5.
Goldberg DJ. Laser therapy. In: Krieg T, Bickers DR, Miyachi Y, editors. Therapy of skin disease. Berlin Heidelberg: Springer; 2010. p. 93-104.
Sardana K, Manjhi M, Garg VK, Sagar V. Which type of atrophic acne scar (ice-pick, boxcar, or rolling) responds to nonablative fractional laser therapy? Dermatol Surg. 2014;40(3):288-300.
Cho SB, Lee SJ, Cho S, Oh SH, Chung WS, Kang JM, et al. Non-ablative 1550-nm erbium-glass and ablative 10600-nm carbon dioxide fractional lasers for acne scars: a randomized split-face study with blinded response evaluation. J Eur Acad Dermatol Venereol. 2010;24(8):921-5.
Lee DH, Choi YS, Min SU, Min SU, Yoon MY, Suh DH. comparison of a 585-nm pulsed dye laser and a 1064-nm Nd:YAG laser for the treatment of acne scars: a randomized split-face clinical study. J Am Acad Dermatol. 2009;60:801-7.
Seaton ED, Mouser PE, Charakida A, Alam S, Seldon PM, Chu AC. Investigation of the mechanism of action of nonablative pulsed-dye laser therapy in photorejuvenation and inflammatory acne vulgaris. Br J Dermatol. 2006;155:748-55.
Goldberg DJ, Silapunt S. Histologic evaluation of a Q-switched Nd: YAG laser in the non ablative treatment of wrinkles. Dermatol Surg. 2001;27:744-6.
Maluki AH, Mohammad FH. Treatment of atrophic facial scars of acne vulgaris by Q-Switched Nd:YAG (Neodymium: Yttrium-Aluminum-Garnet) laser 1064 nm wavelength. J Cosmet Laser Ther. 2012;14(5):224-33.
Friedman PM, Jih MH, Skover GR, et al. Treatment of atrophic facial acne scars with the 1064-nm Q-switched Nd:YAG laser: six-month follow-up study. Arch Dermatol. 2004;140(11):1337-41.
Asilian A, Salimi E, Faghihi G, Dehghani F, Tajmirriahi N, Comparison SMH. of Q-Switched 1064-nm Nd: YAG laser and fractional CO2 laser efficacies on improvement of atrophic facial acne scar. J Res Med Sci. 2011;16(9):1189-95.
Brauer JA, Kazlouskaya V, Alabdulrazzaq H, Bae YS, Bernstein LJ, Anolik R, et al. Use of a picosecond pulse duration laser with specialized optic for treatment of facial acne scarring. JAMA Dermatol. 2015;151(3):278-84.
Bernstein EF, Schomacker KT, Basilavecchio LD, Plugis JM, Bhawalkar JD. Treatment of acne scarring with a novel fractionated, dual-wavelength, picosecond-domain laser incorporating a novel holographic beam-splitter. Lasers Surg Med. 2017;49(9):796-802.
Dierickx C. Using normal and high pulse coverage with picosecond laser treatment of wrinkles and acne scarring: Long term clinical observations. Lasers Surg Med. 2018;50(1):51-5.
Huang CH, Chern E, Peng JH, Hsien-Li Peng P. Noninvasive atrophic acne scar treatment in asians with a 755-nm picosecond laser using a diffractive optic lens-A retrospective photographic review. Dermatol Surg. 2019;45(2):195-202.
Huang CH, Hsieh FS, Chang HC, Peng JH, Peng HP. 755 nm picosecond laser for facial atrophic scar-case reports of long-term clinical efficacy following up. J Cosmet Dermatol. 2019;18:778-82.
Yang C-S, Huang Y-L, Cheng C-Y, Hu S, Chang S-L, Lee M-C. A Prospective study of fractionated dual-wavelength picosecond laser in treating acne scar. Lasers Surg Med. 2020;52(8):735-42.
Kwon HH, Yang SH, Cho YJ, Shin E, Choi M, Bae Y, et al. Comparison of a 1064-nm neodymium-doped yttrium aluminum garnet picosecond laser using a diffractive optical element vs. a nonablative 1550-nm erbium-glass laser for the treatment of facial acne scarring in Asian patients: a 17-week prospective, randomized, split-face, controlled trial. J Eur Acad Dermatol Venereol. 2020;34:2907-13.
Chayavichitsilp P, Limtong P, Triyangkulsri K, Pratumchart N. Comparison of fractional neodymium-doped yttrium aluminum garnet (Nd:YAG) 1064-nm picosecond laser and fractional 1550-nm erbium fiber laser in facial acne scar treatment. Lasers Med Sci. 2020;35:695-700.
Lolis MS, Goldberg DJ. radiofrequency in cosmetic dermatology: a review. Dermatol Surg. 2012;38:1765-76.
Min S, Park SY, Yoon JY, Suh DH. comparison of fractional microneedling radiofrequency and bipolar radiofrequency on acne and acne scar and investigation of mechanism: comparative randomized controlled clinical trial. Arch Dermatol Res. 2015;307:897-904.
Elman M, Fournier N, Barnéon G, Bernstein EF, Lask G. Fractional treatment of aging skin with Tixel, a clinical and histological evaluation. J Cosmet Laser Ther. 2016;18(1):31-7.
Artzi O, Koren A, Niv R, Mehrabi JN, Mashiah J, Friedman O. A new approach in the treatment of pediatric hypertrophic burn scars: tixel-associated topical triamcinolone acetonide and 5-fluorouracil delivery. J Cosmet Dermatol. 2020;19(1):131-4.
Shavit R, Dierickx C. A new method for percutaneous drug delivery by thermo-mechanical fractional injury. Lasers Surg Med. 2020;52(1):61-9.
Saray Y, Güleç AT. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Int J Dermatol. 2005;44(9):777-84.
Levenberg A, Vinshtok Y, Artzi O. Potentials for implementing pressure-controlled jet injection in management of keloids with intralesional 5FU and corticosteroids. J Cosmet Dermatol. 2020;19(8):1966-72.
Patel T, Tevet O. Effective treatment of acne scars using pneumatic injection of hyaluronic acid. J Drugs Dermatol. 2015;14(1):74-6.
Kim BY, Chun SH, Park JH, Ryu S, Kim Il-H. Prospective evaluation of atrophic acne scars on the face with needle-free high-pressure pneumatic injection: quantitative volumetric scar improvement. Dermatol Surg. 2019;45(6):829-35.
Fife D, Zachary CB. Combining techniques for treating acne scars. Curr Dermatol Rep. 2012;1:82-8.
Sadove R. Injectable poly-L lactic acid: a novel sculpting agent for the treatment of dermal fat atrophy after severe acne. Aesthetic Plast Surg. 2009;33:113-6.
Rkein A, Ozog D, Waibel JS. Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-L-lactic acid. Dermatol Surg. 2014;40(6):624-31.
Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34(5):426-38.
Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg. 2008;34(3):301-5.
Cheyasak N, Manuskiatti W, Maneeprasopchoke P, Wanitphakdeedecha R. Topical corticosteroids minimise the risk of postinflammatory hyper-pigmentation after ablative fractional CO2 laser resurfacing in Asians. Acta Derm Venereol. 2015;95(2):201-5.